Novel multiplex assay platforms to detect influenza A hemagglutinin subtype-specific antibody responses for high-throughput and in-field applications.
Identifieur interne : 000038 ( PubMed/Corpus ); précédent : 000037; suivant : 000039Novel multiplex assay platforms to detect influenza A hemagglutinin subtype-specific antibody responses for high-throughput and in-field applications.
Auteurs : Zhu-Nan Li ; Jessica F. Trost ; Kimberly M. Weber ; Elizabeth H. Lemasters ; Sharifa Nasreen ; Javan Esfandiari ; Angelo H. Gunasekera ; Megan Mccausland ; Katharine Sturm-Ramirez ; Jens Wrammert ; Sean Gregory ; Vic Veguilla ; James Stevens ; Joseph D. Miller ; Jacqueline M. Katz ; Min Z. LevineSource :
- Influenza and other respiratory viruses [ 1750-2659 ] ; 2017.
English descriptors
- KwdEn :
- Animals, Antibodies, Viral (blood), Antibodies, Viral (immunology), Bangladesh, Bird Diseases (blood), Bird Diseases (virology), Birds, Cross Reactions, Hemagglutinin Glycoproteins, Influenza Virus (immunology), High-Throughput Screening Assays (methods), Humans, Immunoassay (methods), Influenza A virus (classification), Influenza A virus (immunology), Influenza A virus (isolation & purification), Influenza, Human (blood), Influenza, Human (virology), Species Specificity.
- MESH :
- chemical , blood : Antibodies, Viral.
- chemical , immunology : Antibodies, Viral, Hemagglutinin Glycoproteins, Influenza Virus.
- geographic : Bangladesh.
- blood : Bird Diseases, Influenza, Human.
- classification : Influenza A virus.
- immunology : Influenza A virus.
- isolation & purification : Influenza A virus.
- methods : High-Throughput Screening Assays, Immunoassay.
- virology : Bird Diseases, Influenza, Human.
- Animals, Birds, Cross Reactions, Humans, Species Specificity.
Abstract
Detections of influenza A subtype-specific antibody responses are often complicated by the presence of cross-reactive antibodies. We developed two novel multiplex platforms for antibody detection. The multiplexed magnetic fluorescence microsphere immunoassay (MAGPIX) is a high-throughput laboratory-based assay. Chembio Dual Path Platform (DPP) is a portable and rapid test that could be used in the field.
DOI: 10.1111/irv.12449
PubMed: 28207986
Links to Exploration step
pubmed:28207986Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Novel multiplex assay platforms to detect influenza A hemagglutinin subtype-specific antibody responses for high-throughput and in-field applications.</title><author><name sortKey="Li, Zhu Nan" sort="Li, Zhu Nan" uniqKey="Li Z" first="Zhu-Nan" last="Li">Zhu-Nan Li</name><affiliation><nlm:affiliation>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Trost, Jessica F" sort="Trost, Jessica F" uniqKey="Trost J" first="Jessica F" last="Trost">Jessica F. Trost</name><affiliation><nlm:affiliation>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Weber, Kimberly M" sort="Weber, Kimberly M" uniqKey="Weber K" first="Kimberly M" last="Weber">Kimberly M. Weber</name><affiliation><nlm:affiliation>Battelle Memorial Institute, Columbus, OH, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Lemasters, Elizabeth H" sort="Lemasters, Elizabeth H" uniqKey="Lemasters E" first="Elizabeth H" last="Lemasters">Elizabeth H. Lemasters</name><affiliation><nlm:affiliation>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Nasreen, Sharifa" sort="Nasreen, Sharifa" uniqKey="Nasreen S" first="Sharifa" last="Nasreen">Sharifa Nasreen</name><affiliation><nlm:affiliation>Centre for Communicable Diseases, The International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.</nlm:affiliation></affiliation></author><author><name sortKey="Esfandiari, Javan" sort="Esfandiari, Javan" uniqKey="Esfandiari J" first="Javan" last="Esfandiari">Javan Esfandiari</name><affiliation><nlm:affiliation>Chembio Diagnostic Systems, Inc, Medford, NY, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Gunasekera, Angelo H" sort="Gunasekera, Angelo H" uniqKey="Gunasekera A" first="Angelo H" last="Gunasekera">Angelo H. Gunasekera</name><affiliation><nlm:affiliation>Chembio Diagnostic Systems, Inc, Medford, NY, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Mccausland, Megan" sort="Mccausland, Megan" uniqKey="Mccausland M" first="Megan" last="Mccausland">Megan Mccausland</name><affiliation><nlm:affiliation>Department of Microbiology and Immunology, Emory University, Atlanta, GA, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Sturm Ramirez, Katharine" sort="Sturm Ramirez, Katharine" uniqKey="Sturm Ramirez K" first="Katharine" last="Sturm-Ramirez">Katharine Sturm-Ramirez</name><affiliation><nlm:affiliation>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Wrammert, Jens" sort="Wrammert, Jens" uniqKey="Wrammert J" first="Jens" last="Wrammert">Jens Wrammert</name><affiliation><nlm:affiliation>Department of Microbiology and Immunology, Emory University, Atlanta, GA, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Gregory, Sean" sort="Gregory, Sean" uniqKey="Gregory S" first="Sean" last="Gregory">Sean Gregory</name><affiliation><nlm:affiliation>Battelle Memorial Institute, Columbus, OH, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Veguilla, Vic" sort="Veguilla, Vic" uniqKey="Veguilla V" first="Vic" last="Veguilla">Vic Veguilla</name><affiliation><nlm:affiliation>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Stevens, James" sort="Stevens, James" uniqKey="Stevens J" first="James" last="Stevens">James Stevens</name><affiliation><nlm:affiliation>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Miller, Joseph D" sort="Miller, Joseph D" uniqKey="Miller J" first="Joseph D" last="Miller">Joseph D. Miller</name><affiliation><nlm:affiliation>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Katz, Jacqueline M" sort="Katz, Jacqueline M" uniqKey="Katz J" first="Jacqueline M" last="Katz">Jacqueline M. Katz</name><affiliation><nlm:affiliation>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Levine, Min Z" sort="Levine, Min Z" uniqKey="Levine M" first="Min Z" last="Levine">Min Z. Levine</name><affiliation><nlm:affiliation>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:28207986</idno><idno type="pmid">28207986</idno><idno type="doi">10.1111/irv.12449</idno><idno type="wicri:Area/PubMed/Corpus">000038</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000038</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Novel multiplex assay platforms to detect influenza A hemagglutinin subtype-specific antibody responses for high-throughput and in-field applications.</title><author><name sortKey="Li, Zhu Nan" sort="Li, Zhu Nan" uniqKey="Li Z" first="Zhu-Nan" last="Li">Zhu-Nan Li</name><affiliation><nlm:affiliation>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Trost, Jessica F" sort="Trost, Jessica F" uniqKey="Trost J" first="Jessica F" last="Trost">Jessica F. Trost</name><affiliation><nlm:affiliation>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Weber, Kimberly M" sort="Weber, Kimberly M" uniqKey="Weber K" first="Kimberly M" last="Weber">Kimberly M. Weber</name><affiliation><nlm:affiliation>Battelle Memorial Institute, Columbus, OH, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Lemasters, Elizabeth H" sort="Lemasters, Elizabeth H" uniqKey="Lemasters E" first="Elizabeth H" last="Lemasters">Elizabeth H. Lemasters</name><affiliation><nlm:affiliation>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Nasreen, Sharifa" sort="Nasreen, Sharifa" uniqKey="Nasreen S" first="Sharifa" last="Nasreen">Sharifa Nasreen</name><affiliation><nlm:affiliation>Centre for Communicable Diseases, The International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.</nlm:affiliation></affiliation></author><author><name sortKey="Esfandiari, Javan" sort="Esfandiari, Javan" uniqKey="Esfandiari J" first="Javan" last="Esfandiari">Javan Esfandiari</name><affiliation><nlm:affiliation>Chembio Diagnostic Systems, Inc, Medford, NY, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Gunasekera, Angelo H" sort="Gunasekera, Angelo H" uniqKey="Gunasekera A" first="Angelo H" last="Gunasekera">Angelo H. Gunasekera</name><affiliation><nlm:affiliation>Chembio Diagnostic Systems, Inc, Medford, NY, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Mccausland, Megan" sort="Mccausland, Megan" uniqKey="Mccausland M" first="Megan" last="Mccausland">Megan Mccausland</name><affiliation><nlm:affiliation>Department of Microbiology and Immunology, Emory University, Atlanta, GA, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Sturm Ramirez, Katharine" sort="Sturm Ramirez, Katharine" uniqKey="Sturm Ramirez K" first="Katharine" last="Sturm-Ramirez">Katharine Sturm-Ramirez</name><affiliation><nlm:affiliation>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Wrammert, Jens" sort="Wrammert, Jens" uniqKey="Wrammert J" first="Jens" last="Wrammert">Jens Wrammert</name><affiliation><nlm:affiliation>Department of Microbiology and Immunology, Emory University, Atlanta, GA, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Gregory, Sean" sort="Gregory, Sean" uniqKey="Gregory S" first="Sean" last="Gregory">Sean Gregory</name><affiliation><nlm:affiliation>Battelle Memorial Institute, Columbus, OH, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Veguilla, Vic" sort="Veguilla, Vic" uniqKey="Veguilla V" first="Vic" last="Veguilla">Vic Veguilla</name><affiliation><nlm:affiliation>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Stevens, James" sort="Stevens, James" uniqKey="Stevens J" first="James" last="Stevens">James Stevens</name><affiliation><nlm:affiliation>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Miller, Joseph D" sort="Miller, Joseph D" uniqKey="Miller J" first="Joseph D" last="Miller">Joseph D. Miller</name><affiliation><nlm:affiliation>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Katz, Jacqueline M" sort="Katz, Jacqueline M" uniqKey="Katz J" first="Jacqueline M" last="Katz">Jacqueline M. Katz</name><affiliation><nlm:affiliation>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Levine, Min Z" sort="Levine, Min Z" uniqKey="Levine M" first="Min Z" last="Levine">Min Z. Levine</name><affiliation><nlm:affiliation>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Influenza and other respiratory viruses</title><idno type="eISSN">1750-2659</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Antibodies, Viral (blood)</term><term>Antibodies, Viral (immunology)</term><term>Bangladesh</term><term>Bird Diseases (blood)</term><term>Bird Diseases (virology)</term><term>Birds</term><term>Cross Reactions</term><term>Hemagglutinin Glycoproteins, Influenza Virus (immunology)</term><term>High-Throughput Screening Assays (methods)</term><term>Humans</term><term>Immunoassay (methods)</term><term>Influenza A virus (classification)</term><term>Influenza A virus (immunology)</term><term>Influenza A virus (isolation & purification)</term><term>Influenza, Human (blood)</term><term>Influenza, Human (virology)</term><term>Species Specificity</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Antibodies, Viral</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Antibodies, Viral</term><term>Hemagglutinin Glycoproteins, Influenza Virus</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Bangladesh</term></keywords><keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Bird Diseases</term><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="classification" xml:lang="en"><term>Influenza A virus</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza A virus</term></keywords><keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Influenza A virus</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>High-Throughput Screening Assays</term><term>Immunoassay</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Bird Diseases</term><term>Influenza, Human</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Birds</term><term>Cross Reactions</term><term>Humans</term><term>Species Specificity</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Detections of influenza A subtype-specific antibody responses are often complicated by the presence of cross-reactive antibodies. We developed two novel multiplex platforms for antibody detection. The multiplexed magnetic fluorescence microsphere immunoassay (MAGPIX) is a high-throughput laboratory-based assay. Chembio Dual Path Platform (DPP) is a portable and rapid test that could be used in the field.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28207986</PMID><DateCompleted><Year>2017</Year><Month>08</Month><Day>24</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1750-2659</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>3</Issue><PubDate><Year>2017</Year><Month>05</Month></PubDate></JournalIssue><Title>Influenza and other respiratory viruses</Title><ISOAbbreviation>Influenza Other Respir Viruses</ISOAbbreviation></Journal><ArticleTitle>Novel multiplex assay platforms to detect influenza A hemagglutinin subtype-specific antibody responses for high-throughput and in-field applications.</ArticleTitle><Pagination><MedlinePgn>289-297</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/irv.12449</ELocationID><Abstract><AbstractText Label="BACKGROUND">Detections of influenza A subtype-specific antibody responses are often complicated by the presence of cross-reactive antibodies. We developed two novel multiplex platforms for antibody detection. The multiplexed magnetic fluorescence microsphere immunoassay (MAGPIX) is a high-throughput laboratory-based assay. Chembio Dual Path Platform (DPP) is a portable and rapid test that could be used in the field.</AbstractText><AbstractText Label="METHODS">Twelve recombinant globular head domain hemagglutinin (GH HA1) antigens from A(H1N1)pdm09 (pH1N1), A(H2N2), A(H3N2), A(H5N1), A(H7N9), A(H9N2), A(H13N9), B/Victoria lineage, B/Yamagata lineage viruses, and protein A control were used. Human sera from U.S. residents either vaccinated (with H5N1 or pH1N1) or infected with pH1N1 influenza viruses and sera from live bird market workers in Bangladesh (BDPW) were evaluated. GH HA1 antigens and serum adsorption using full ectodomain recombinant hemagglutinins from A(pH1N1) and A(H3N2) were introduced into the platforms to reduce cross-reactivity.</AbstractText><AbstractText Label="RESULTS">Serum adsorption reduced cross-reactivity to novel subtype HAs. Compared to traditional hemagglutination inhibition or microneutralization assays, when serum adsorption and the highest fold rise in signals were used to determine positivity, the correct subtype-specific responses were identified in 86%-100% of U.S. residents exposed to influenza antigens through vaccination or infection (N=49). For detection of H5N1-specific antibodies in sera collected from BDPW, H5 sensitivity was 100% (six of six) for MAGPIX, 83% (five of six) for DPP, H5 specificity was 100% (15/15), and cross-reactivity against other subtype was 0% (zero of six) for both platforms.</AbstractText><AbstractText Label="CONCLUSION">MAGPIX and DPP platforms can be utilized for high-throughput and in-field detection of novel influenza virus infections.</AbstractText><CopyrightInformation>© 2017 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Zhu-Nan</ForeName><Initials>ZN</Initials><Identifier Source="ORCID">0000-0002-4556-8551</Identifier><AffiliationInfo><Affiliation>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trost</LastName><ForeName>Jessica F</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Emory University, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weber</LastName><ForeName>Kimberly M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Battelle Memorial Institute, Columbus, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>LeMasters</LastName><ForeName>Elizabeth H</ForeName><Initials>EH</Initials><AffiliationInfo><Affiliation>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nasreen</LastName><ForeName>Sharifa</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centre for Communicable Diseases, The International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Esfandiari</LastName><ForeName>Javan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Chembio Diagnostic Systems, Inc, Medford, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gunasekera</LastName><ForeName>Angelo H</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>Chembio Diagnostic Systems, Inc, Medford, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCausland</LastName><ForeName>Megan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Emory University, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sturm-Ramirez</LastName><ForeName>Katharine</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Communicable Diseases, The International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wrammert</LastName><ForeName>Jens</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Emory University, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gregory</LastName><ForeName>Sean</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Battelle Memorial Institute, Columbus, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Veguilla</LastName><ForeName>Vic</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stevens</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Joseph D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katz</LastName><ForeName>Jacqueline M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levine</LastName><ForeName>Min Z</ForeName><Initials>MZ</Initials><AffiliationInfo><Affiliation>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D023362">Evaluation Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>04</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Influenza Other Respir Viruses</MedlineTA><NlmUniqueID>101304007</NlmUniqueID><ISSNLinking>1750-2640</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019267">Hemagglutinin Glycoproteins, Influenza Virus</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001459" MajorTopicYN="N" Type="Geographic">Bangladesh</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001715" MajorTopicYN="N">Bird Diseases</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001717" MajorTopicYN="N">Birds</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003429" MajorTopicYN="N">Cross Reactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019267" MajorTopicYN="N">Hemagglutinin Glycoproteins, Influenza Virus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057166" MajorTopicYN="N">High-Throughput Screening Assays</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007118" MajorTopicYN="N">Immunoassay</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009980" MajorTopicYN="N">Influenza A virus</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013045" MajorTopicYN="N">Species Specificity</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">MAGPIX
</Keyword><Keyword MajorTopicYN="Y">Chembio Dual Path Platform</Keyword><Keyword MajorTopicYN="Y">antibody</Keyword><Keyword MajorTopicYN="Y">hemagglutinin</Keyword><Keyword MajorTopicYN="Y">influenza</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>02</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>8</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28207986</ArticleId><ArticleId IdType="doi">10.1111/irv.12449</ArticleId><ArticleId IdType="pmc">PMC5410722</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Clin Vaccine Immunol. 2011 Aug;18(8):1205-12</Citation><ArticleIdList><ArticleId IdType="pubmed">21653743</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Clin Vaccine Immunol. 2011 Sep;18(9):1524-6</Citation><ArticleIdList><ArticleId IdType="pubmed">21795463</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Clin Microbiol. 1985 May;21(5):847-9</Citation><ArticleIdList><ArticleId IdType="pubmed">3839001</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>PLoS One. 2014 Nov 18;9(11):e113021</Citation><ArticleIdList><ArticleId IdType="pubmed">25405997</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 1982 Aug;79(15):4800-4</Citation><ArticleIdList><ArticleId IdType="pubmed">6956892</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Clin Microbiol Infect. 2012 Aug;18(8):797-807</Citation><ArticleIdList><ArticleId IdType="pubmed">22212116</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol Methods. 2014 Dec;209:121-5</Citation><ArticleIdList><ArticleId IdType="pubmed">25239367</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Emerg Infect Dis. 2015 Apr;21(4):629-37</Citation><ArticleIdList><ArticleId IdType="pubmed">25811942</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>PLoS One. 2014 Sep 23;9(9):e108043</Citation><ArticleIdList><ArticleId IdType="pubmed">25248105</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Sci Rep. 2016 Feb 08;6:20385</Citation><ArticleIdList><ArticleId IdType="pubmed">26853924</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Virology. 2015 Mar;477:18-31</Citation><ArticleIdList><ArticleId IdType="pubmed">25617824</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>PLoS One. 2016 Mar 24;11(3):e0152131</Citation><ArticleIdList><ArticleId IdType="pubmed">27010791</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>N Engl J Med. 2009 Nov 12;361(20):1945-52</Citation><ArticleIdList><ArticleId IdType="pubmed">19745214</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Science. 2004 Mar 19;303(5665):1866-70</Citation><ArticleIdList><ArticleId IdType="pubmed">14764887</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Influenza Other Respir Viruses. 2017 May;11(3):289-297</Citation><ArticleIdList><ArticleId IdType="pubmed">28207986</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Mol Genet Med. 2009 Dec 23;3(2):217-24</Citation><ArticleIdList><ArticleId IdType="pubmed">20076794</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Clin Microbiol. 1999 Apr;37(4):937-43</Citation><ArticleIdList><ArticleId IdType="pubmed">10074505</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Influenza Other Respir Viruses. 2013 Mar;7(2):211-24</Citation><ArticleIdList><ArticleId IdType="pubmed">22548725</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Expert Rev Anti Infect Ther. 2011 Jun;9(6):669-83</Citation><ArticleIdList><ArticleId IdType="pubmed">21692672</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Immunol Methods. 2009 Jan 30;340(2):123-31</Citation><ArticleIdList><ArticleId IdType="pubmed">19000692</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Infect Dis. 2013 Aug 15;208(4):554-8</Citation><ArticleIdList><ArticleId IdType="pubmed">23687225</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Clin Vaccine Immunol. 2014 Aug;21(8):1054-60</Citation><ArticleIdList><ArticleId IdType="pubmed">24872516</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>PLoS One. 2015 Jun 23;10(6):e0129858</Citation><ArticleIdList><ArticleId IdType="pubmed">26103163</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Clin Diagn Lab Immunol. 2002 Jan;9(1):41-5</Citation><ArticleIdList><ArticleId IdType="pubmed">11777827</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000038 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000038 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= H2N2V1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:28207986
|texte= Novel multiplex assay platforms to detect influenza A hemagglutinin subtype-specific antibody responses for high-throughput and in-field applications.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:28207986" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a H2N2V1
| This area was generated with Dilib version V0.6.33. |  |